Ping An Biomedical Co., Ltd. entered into a Securities Purchase Agreement on February 9, 2026, to issue and sell ordinary shares to investors at a price of US$0.04 per share, subject to closing conditions. This represents a private placement of securities.
Key takeaways
Company entered into a Securities Purchase Agreement dated February 9, 2026.
Agreement is between Ping An Biomedical Co., Ltd. and investors identified on signature pages.
Company will issue and sell ordinary shares to investors.
Purchase price is US$0.04 per share.
Closing will occur on the second Trading Day after the agreement date or later upon satisfaction of conditions.
Shares are ordinary shares with par value $0.0000625 per share.